Week in review: IAEA and PSMA-PET | Multimodal MRI and breast cancer | The Road continues

Of high interest to readers this week was our story about a worldwide trial sponsored by the International Atomic Energy Agency (IAEA) that supports the global adoption of prostate-specific antigen (PSMA) PET/CT into standard staging protocols, as well as an article on how deep feature extraction and MRI radiomics can help predict survival in breast cancer patients treated with neoadjuvant chemotherapy.

Our continued Road to RSNA coverage also took top spots, with previews of molecular imaging, digital x-ray, CT imaging, and imaging informatics. Click here to peruse all of our pre-RSNA coverage, including our last installment, ultrasound.

Finally, check out our coverage of GE HealthCare's bid to acquire Intelerad for $2.3 billion.

For the full list of the week's most-read stories, see below.

1. IAEA recommends global adoption of PSMA-PET
2. Multimodal MRI model predicts survival in breast cancer patients
3. Road to RSNA 2025: Molecular Imaging Preview
4. Road to RSNA 2025: Digital X-Ray Preview
5. Road to RSNA 2025: CT Preview
6. Road to RSNA 2025: Imaging Informatics Preview
7. GE HealthCare inks deal to acquire Intelerad for $2.3B
8. Integrated cardiac workflow, imaging tools transform access/demand equation
9. Partial breast irradiation effective in women with HR+ cancers
10. Stress coping may protect against cognitive decline
11. LLMs improve patient comprehension of oncologic CT reports
12. LLMs fit for writing mock rad tech exams
13. X-rays predict mortality following hip fracture surgery
14. CT use in the emergency department has increased more than 2-fold

Kate Madden Yee
Senior Editor
AuntMinnie.com